2009-04-30 - Rockwell Completes Patient Enrollment for Phase 2b Study
... having study data available in the fourth quarter of 2009 and shortly thereafter
commencing our Phase 3 program,” said Robert L. Chioini, chairman, CEO and ...
www.renalbusiness.com/news/2009/04/rockwell-completes-patient-enrollment-for-phase-2.aspx - 41k
2009-04-16 - Rockwell Medical Updates DSMB Interim Results
... Robert L. Chioini, Rockwell’s chairman, CEO and president, said: "We are again
encouraged by the DSMB's favorable comments regarding our current SFP Phase 2b ...
www.renalbusiness.com/news/2009/04/rockwell-medical-updates-dsmb-interim-results.aspx - 40k
2009-10-07 - Rockwell Appoints Strobos to Scientific Advisory Board
... to both FDA clinical drug development and corporate drug development, and he knows
the renal space particularly well,” said Robert L. Chioini, chairman, CEO ...
www.renalbusiness.com/news/2009/10/rockwell-appoints-strobos-to-scientific-advisory.aspx - 39k
2009-06-29 - Rockwell Medical Technologies Named to Russell Indexes
... "We are pleased to be included in these new Russell US and Global Indexes,"
said Robert Chioini, Rockwell’s president and CEO. ...
www.renalbusiness.com/news/2009/06/rockwell-medical-technologies-named-to-russell-in.aspx - 38k
2007-07-02 - Rockwell gets Japanese patent for iron-delivery drug
... “This is another important patent approval for Rockwell,” Robert Chioini,
Rockwell chairman and CEO, said in a statement. “Coupled ...
www.renalbusiness.com/articles/2007/07/rockwell-gets-japanese-patent-for-iron-delivery-d.aspx - 41k
2007-02-05 - Rockwell Medical upgrades to Nasdaq Global Market
... Nasdaq Global Market sets higher requirements of stockholder’s equity, net income
and market value,” Rockwell’s President and CEO Robert Chioini said in ...
www.renalbusiness.com/articles/2007/02/rockwell-medical-upgrades-to-nasdaq-global-market.aspx - 38k
2007-01-05 - Rockwell Medical upgrades to Nasdaq Global Market
... "The Nasdaq Global Market sets higher requirements of stockholder's equity, net
income and market value," Rockwell's President and CEO Robert Chioini said in a ...
www.renalbusiness.com/news/2007/01/rockwell-medical-upgrades-to-nasdaq-global-market.aspx - 39k
2010-10-26 - Rockwell's Iron Deficiency Drug Receives Patent
... It also provides patent protection for the multiple indications Rockwell intends
to develop using the SFP technology," said Robert L. Chioini, chairman, CEO ...
www.renalbusiness.com/news/2010/10/rockwells-iron-deficiency-drug-receives-patent.aspx - 40k
2010-07-08 - Rockwell, FDA Complete Phase II Meeting for Iron Drug
... Phase IIb data and solicit input for our planned Phase III program was an important
corporate and clinical milestone," said Robert L. Chioini, chairman, CEO ...
www.renalbusiness.com/news/2010/07/rockwell-fda-complete-phase-ii-meeting-for-iron-drug.aspx - 40k
2011-03-28 - Rockwell, DaVita Sign Supply Agreement
... have executed this multi-year supply agreement with DaVita, further strengthening
our long-standing business relationship," said Robert Chioini, chairman and ...
www.renalbusiness.com/news/2011/03/rockwell-davita-sign-supply-agreement.aspx - 38k
